10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)

Isabel Syndikus, Clare Griffin, Lara Philipps, Alison Tree, Vincent Khoo, Alison Jane Birtle, Ananya Choudhury, Catherine Ferguson, Joe M. O'Sullivan, Miguel Panades, Yvonne L. Rimmer, Christopher D. Scrase, John Staffurth, Clare Cruickshank, Shama Hassan, Julia Pugh, David P. Dearnaley, Emma Hall

Research output: Contribution to journalMeeting abstractpeer-review

Fingerprint

Dive into the research topics of '10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)'. Together they form a unique fingerprint.